NeuroSense Therapeutics L...

NASDAQ: NRSN · Real-Time Price · USD
1.20
0.03 (2.56%)
At close: Aug 15, 2025, 3:59 PM
1.20
0.42%
After-hours: Aug 15, 2025, 06:33 PM EDT

NeuroSense Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
3.38M 344K 1.21M 771K 2.68M 4.76M 7.09M 1.36M 3.54M 4.41M 4.35M 8.73M 11.06M 994K -699K
Short-Term Investments
n/a n/a 35K n/a n/a n/a n/a 3.05M 3.55M 4.03M 6.03M 5M n/a n/a 1.4M
Long-Term Investments
n/a n/a n/a 23K 22K 21K 23K 23K 23K 34K 35K n/a n/a n/a n/a
Other Long-Term Assets
23K 23K 22K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 37K -699K
Receivables
164K 406K 376K 421K 166K 309K 434K 567K 131K 425K 707K 225K 178K n/a n/a
Inventory
n/a n/a n/a -457K n/a 36.65K 37.53K 38.39K -3.68M n/a n/a -225K -178K -16K n/a
Other Current Assets
35K 35K n/a n/a n/a 346.00 472.00 606.00 36K 23K 23K 64K 171K n/a n/a
Total Current Assets
4.4M 785K 1.62M 1.19M 2.92M 5.11M 7.56M 5.02M 7.38M 8.89M 11.1M 14.03M 11.41M 1.01M 699K
Property-Plant & Equipment
150K 176K 200K 231K 238K 260K 284K 294K 306K 304K 314K 329K 19K 15K n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
173K 199K 222K 254K 260K 281K 307K 317K 329K 338K 349K 329K 19K 52K -699K
Total Assets
4.58M 984K 1.84M 1.45M 3.18M 5.39M 7.87M 5.33M 7.71M 9.23M 11.45M 14.36M 11.43M 1.06M n/a
Account Payables
1.16M 1.39M 1.48M 2.38M 1.46M 913K 1.09M 419K 498K 206K 120K 180K 39K 12K n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
261K n/a 2.02M 2.15M 614K 1.9M 1.92M 1.37M 413K 605K 616K 1.05M n/a n/a n/a
Total Current Liabilities
1.99M 3.78M 3.51M 4.54M 3.46M 2.81M 3M 1.79M 1.73M 811K 736K 1.23M 597K 125K n/a
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a 147K n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a 3.85M 1.52M 2.69M 6.3M 527K 71K 400K 691K 816K 1.83M n/a n/a
Total Long-Term Liabilities
n/a 19K 36K 3.9M 1.59M 2.77M 6.41M 653K 365K 573K 881K 1.02M 1.83M n/a n/a
Total Liabilities
1.99M 3.8M 3.54M 8.44M 5.05M 5.58M 9.41M 2.45M 2.09M 1.38M 1.62M 2.25M 2.42M 125K n/a
Total Debt
73K 19K 36K 55K 142K 84K 104K 126K 211K 173K 190K 207K n/a n/a n/a
Common Stock
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Retained Earnings
-36.66M -34.53M -32.38M -31.52M -32.07M -29.12M -29.9M -24.68M -20.79M -17.64M -14.64M -11.16M -8.45M -7.46M n/a
Comprehensive Income
n/a n/a n/a 24.53M 30.19M 28.92M 28.36M 27.56M 26.41M 25.48M 24.48M 23.27M -0.00 n/a 659K
Shareholders Equity
2.58M -2.82M -1.7M -6.99M -1.87M -196K -1.54M 2.89M 5.62M 7.85M 9.84M 12.11M 9.01M 937K 659K
Total Investments
n/a n/a 22K 23K 22K 21K 23K 3.05M 3.55M 4.03M 6.03M 5M n/a n/a 1.4M